Lecanemab's success was hailed a 'historic moment' after landmark trials showed it can halt the declines in memory and thinking among patients in the earliest stages.
The drug, given as an injection, was designed to clear a build up of amyloid — toxic plaques in the brain that are thought to cause the cruel, memory-robbing disease. The Daily Mail
No comments:
Post a Comment